ahro20141113_nt10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 12b-25

 

 

 

OMB APPROVAL

OMB Number: 3235-0058

Expires:

Estimated average burden hours per response…2.50

 

 

SEC File Number: 000-52315

 

CUSIP Number: 047438 304

 

NOTIFICATION OF LATE FILING

 

 

(Check one)      _____Form 10-K     _____Form 20-F     _____Form 11-K

 

__X__Form 10-Q     _____Form 10-D     _____Form N-SAR      _____Form-CSR

 

For period ended _September 30, 2014_

 

 

☐Transition Report on Form 10-K

 

☐Transition Report on Form 20-F

 

☐Transition Report on Form 11-K

 

☐Transition Report on Form 10-Q

 

☐Transition Report on Form N-SAR

 

For the transition period ended _____________________________________

 

 

Nothing in this form shall be construed to imply that the Commission

has verified any information contained herein.

 

 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

 

 

 

 

 
12b25-1
 

  

PART I

REGISTRANT INFORMATION

 

Full Name of Registrant

AtheroNova Inc.  

 

 

 

Former Name if Applicable

 

 

 

 

 Address of Principal Executive Office (Street and Number)

2301 Dupont Drive, Suite 525 

 

 

 

City, State and Zip Code 

Irvine, CA 92612 

 

 

PART II

RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

☒

(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

 

 

  (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
   
 

(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III

NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

The registrant’s Form 10-Q for the fiscal quarter ended September 20, 2014 could not be filed within the prescribed time period due to matters relating to outstanding indebtedness the resolution of which will affect the financial statements for the period ended September 30, 2014, which could not be eliminated without unreasonable effort or expense.

 

PART IV

OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Mark Selawski 

 

(949) 

 

476-1100 

(Name) 

 

(Area Code)  

 

(Telephone Number)

 

 
12b25-2
 

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).                                        ☒Yes ☐No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?                                   ☐Yes    ☒No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

AtheroNova Inc. 

(Name of Registrant as Specified in Charter) 

 

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date

 November 14, 2014

 

By 

/s/ Mark Selawski 

 

 

 

 

 

 

 

 

Name: 

Mark Selawski 

 

 

 

 

 

 

 

 

Title: 

Chief Financial Officer 

 

ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations

(See 18 U.S.C. 1001).

 

 
12b25-3
 

  

Part IV – Other Information

 

(3) Explanation of Change

 

The Registrant anticipates that the resolution of issues relating to the outstanding indebtedness will affect the financial statements for the period ending September 30, 2014 and the presentation thereof.